Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07523867) titled 'Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study' on April 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Condition:
Heart Failure
Diabetic Kidney Disease
Hyperkalemia
Intervention:
Drug: Finerenone
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: April 2026
Target Sample Size: 60
To know more, visit https://clinicaltrials.gov/study/NCT07523867...